PPARG and osteoporosis: Even though a lot is known about the way agonists interact with PPARγ to elicit its role in various processes—predominantly adipogenesis, PPARγ antagonism is just starting to be understood in relation to its role in bone biology and especially in chronic bone diseases like osteoporosis.